Digital Market Research &  Real – World Insights

Digital Market Research & Real – World Insights

Market Research, HCPs survey, Patient’s survey
MphaR Our Services Digital Market Research & Real – World Insights

Evidence-Based Insights to Guide Smarter Medical and Strategic Decisions

At MphaR, we deliver high-quality, scientifically grounded market research that helps Medical Affairs teams understand the real needs, perceptions, and expectations of healthcare professionals, patients, and stakeholders. Our approach blends rigorous methodology with medical expertise, enabling companies to make confident, data-driven decisions throughout the product lifecycle.

We design and execute market research programs that uncover meaningful, actionable insights—whether you’re exploring new therapeutic opportunities, evaluating medical education impact, validating unmet needs, or refining scientific communication strategy.

Market Research Services

What We Offer

HCP, KOL & Stakeholder Insights

We conduct structured interviews, advisory discussions, surveys, and qualitative/quantitative studies to map clinical behaviours, treatment patterns, educational preferences, and key decision drivers across specialties and regions.

Patient & Caregiver Perspectives

We collaborate with patient communities and advocacy groups to capture real-world experiences, disease burdens, journey barriers, and quality-of-life needs—critical inputs for evidence generation and meaningful engagement.

Competitor & Landscape Analysis

Our experts evaluate scientific environments, competitive activities, congress insights, publication trends, and pipeline developments to provide a clear view of your therapeutic landscape.

Unmet Needs Identification

Through structured analysis, we highlight gaps in clinical practice, knowledge, data, or disease management—enabling Medical Affairs to define impactful strategic priorities.

Pre-Launch & Launch Readiness Insights

We assess perceptions of new therapies, clinical applicability, barriers to adoption, and communication needs to help shape strong and scientifically credible launch strategies.

Post-Launch Performance Tracking

We monitor evolving clinical behavior, engagement preferences, and sentiment to help teams optimize ongoing Medical Affairs activities.

Our Approach

Robust Methodology

We combine qualitative and quantitative research, triangulated with literature and real-world data, to deliver validated insights.

Scientific Rigor

All studies are designed and interpreted by scientific professionals with deep therapeutic area expertise.

Global Reach

Our international network enables research across multiple geographies with consistent quality, compliance, and methodology.

Actionable Outcomes

Every project concludes with clear recommendations, strategic implications, and data visualizations to empower medical and commercial teams.

Outcome: Insights that Shape Strategy

Our market research transforms raw data into scientific intelligence—helping you make informed decisions, enhance stakeholder engagement, and deliver better patient outcomes.

Digital-First Execution

Using the MphaR digital platform, we support:

  • Secure online surveys
  • Real-time polling
  • Virtual focus groups and discussion forums
  • Asynchronous insights collection
  • Document and evidence review

This increases engagement, reduces timelines, and broadens global participation.

Why Partner with MphaR?

Deep experience collaborating with patient advocacy organizations

Digital tools that enhance access, engagement, and measurement

Ability to scale programs across languages and geographies

Proven ability to translate complex science into patient-friendly communication

Strong commitment to empathy, transparency, and patient empowerment

Case Study

Planned F2F Advisory Board on Non-Small Cell Lung Cancer (NSCLC) Switched to Virtual Format

Top-Notch Advisory Board in Metastatic Breast Cancer Executed in Virtual Format

Hemophdia a Virtual Advisory Board with Patient Advocacy (PAGS)

Virtual Advisory Board with Payers

Improving the Treatment Care of Patients with Multiple Myeloma Through Regular Connection between International and National Rheumatologists in…

NSCLC Virtual Advisory Board with Global Oncologists

Generating Independent Real-World Data (RWD)

Reliable, Efficient, and Unbiased Real-World Insights to Guide Medical Affairs Strategy

MphaR supports Medical Affairs teams in generating independent Real-World Data through scientifically designed surveys involving healthcare professionals, patients, and caregivers. Our approach provides rapid, trustworthy evidence that helps teams understand real clinical behaviors, unmet needs, and therapeutic challenges.

Why independent RWD matters:

  • Initiated and guided by a Steering Committee to ensure scientific credibility
  • Shorter timelines from project initiation to final publication
  • Lower overall costs compared with traditional research programs
  • Reliable, validated data collection supported by our digital platform
  • Applicable across therapeutic areas, from oncology to rare diseases to chronic conditions

Independent RWD allows organizations to make stronger, evidence-based decisions that directly impact patient outcomes.

Research Strategy & Milestones

A structured pathway from scientific question to publication

MphaR manages the complete lifecycle of independent research projects—from concept definition to congress abstracts and manuscript publications. Each initiative follows a clear, predictable framework:

step 1

Advisory Board (January-February)

Milestones
  • Scientific briefing of Advisory Board members
  • Development of survey goals, research questions, and core topics
  • Drafting and refinement of slide materials for Live Video Meetings (LVM)
  • Compliance review and approvals

This stage ensures scientific robustness and alignment across experts.

step 2

Survey Phase (March – July)

Milestones
  • Survey instrument design (HCP, patient, caregiver, or mixed models)
  • Digital distribution via the MphaR platform
  • Data cleaning, validation, and quality checks
  • Statistical analysis

The survey captures real-world insights quickly and at scale.

step 3

Publication Phase (October – December)

Milestones
  • Scientific briefing of Advisory Board members
  • Drafting of the full scientific manuscript
  • Submission and publication in peer-reviewed journals

The final output provides high-impact scientific evidence that supports education, strategy, and global communication.

Examples of Independent Research Initiatives

Global, multi-stakeholder insights powered by MphaR

We have executed independent, multi-country studies across a wide range of therapeutic areas. Examples include:

MATTER Study

Multi-country physician survey examining treatment practices in:

  • Non–muscle-invasive bladder cancer
  • Muscle-invasive bladder cancer

Regions covered: Europe, Middle East, Asia, Australia, LATAM

VIEW Study

Caregiver survey focused on lung cancer (NSCLC) across multiple regions.

Aim: Collect real-world evidence from informal caregivers of advanced/metastatic NSCLC patients, including those in ≥1 line of therapy.

OLIVIA Study

Global patient experience survey exploring knowledge gaps and treatment journeys of HR+/HER2– metastatic breast cancer patients across multiple treatment lines (1L, 2L, later lines).

How These Initiatives Add Value

Across all projects, MphaR provides:

Full methodology and scientific oversight

Digital-first execution for efficient global engagement

Compliance support from planning to publication

Expert interpretation to ensure meaningful conclusions

Rapid delivery timelines without compromising quality

What HCPs and Medical Affairs Experts Tell About Working with Us

We work closely with HCPs and Medical Affairs experts worldwide. Here’s what they share about partnering with MphaR

Medical Affairs Trends: Blog, Digest and Podcasts

Stay informed on emerging Medical Affairs trends with expert blog articles, and twice-monthly editions of our Medical Affairs Digest and podcasts series.

TrendWatch: Medical Affairs

Explore concise articles covering the latest trends and innovations in Medical Affairs

Latest Article

Virtual Reality in Medical Training: Immersive Learning Experiences

Contemporary medical education faces limitations in clinical exposure and resources, but virtual reality (VR) has emerged as a powerful solution. By recreating realistic and interactive clinical environments, VR allows healthcare professionals to actively engage in simulated experiences, enhancing skill refinement in a safe and scalable manner. Ultimately, this immersive technology promises profound improvements in training quality, competency development, and patient safety.

Sustainability in the Pharmaceutical Industry: A Greener Future for Healthcare

This blog post examines the environmental impact of the pharmaceutical industry, including high energy consumption and waste generation. It emphasizes the urgent need for sustainable practices, such as energy efficiency measures, water conservation, and waste reduction, to minimize environmental harm and ensure the industry’s long-term viability.

The Best Icebreakers for Virtual Meetings

The healthcare industry implemented different techniques to make interactions between pharmaceutical companies, healthcare professionals, and general physicians. Icebreakers for virtual meetings make it easy to connect with simple activities to build team camaraderie.

Bi-monthly Newsletter: Medical Affairs Digest

Your bi-monthly overview of essential Medical Affairs updates and emerging industry signals

Latest Newsletter
Bi-Monthly podcasts: Medical Affairs Voices

Listen to expert conversations exploring current trends and future directions in Medical Affairs

Precision Medicine in Oncology: Transforming Cancer Diagnostics Using AI Tools

In this episode, we uncover how artificial intelligence is transforming oncology, marking a shift from standardizedtreatments to precision medicine tailored to each patient’s genetic and molecular profile. From AI-powered imaging and digital pathology to genomic analysis and liquid biopsies, technology is reshaping how cancer is detected, understood, and treated. Hear how these innovations are driving earlier diagnoses, improving treatment accuracy, and empowering clinicians with insights once thought impossible. We also explore the ethical and practical challenges of integrating AI into cancercare and what it means for patients and providers alike. Join us as we look ahead to a future where AI doesn’t replace the human touch—it amplifies it, bringing us closer to truly personalized oncology care.

Leveraging AI and NLP to Transform Medical Information Systems in Medical Affairs

In this episode, we explore how artificial intelligence and natural language processing are reshaping how Medical Affairs teams manage, interpret, and apply vast volumes of unstructured medical information. From scientific literature and safety reports to advisory board insights and field intelligence, NLP is turning free text into structured, actionable knowledge—helping teams move faster while maintaining scientific rigor. Discover how NLP is being applied across literature intelligence, medical information systems, pharmacovigilance, and stakeholder engagement, and why human oversight remains essential in regulated medical environments. We also examine the risks, ethical considerations, and governance frameworks needed to ensure accuracy, transparency, and compliance. Join us as we look ahead to the evolution from language processing to true language understanding—and what this shift means for the future of Medical Affairs as a strategic, insight-driven function.

From Data to Dialogue — Strengthening Patient-Centricity Through Virtual Advisory Boards

In this episode, we examine how Virtual Advisory Boards are revolutionizing patient engagement, turning static data into meaningful dialogue that shapes real-world decisions. As patient-centricity becomes a defining principle in modern pharma, digital platforms are creating space for authentic collaboration between patients, caregivers, and industry leaders. Discover how virtual formats remove barriers to participation, ensure inclusivity, and make continuous patient input a practical reality. We’ll explore how the MphaR Virtual Advisory Board platform enables companies to integrate patient insights into trial design, treatment strategies, and beyond. Tune in as we explore how the future of patient engagement is being built—one conversation at a time—through innovation, empathy, and dialogue that truly puts patients at the center of healthcare.

Follow MphaR on Social Media:

MphaR Our Services Digital Market Research & Real – World Insights

FAQs

Yes. We are experienced in hard-to-reach disease areas and recruit suitable experts, HCPs, or patients if needed.
Yes. We support interviews, focus groups, surveys, landscaping mapping, and data-based analysis.
Most projects take 2-4 months, depending on recruitment needs and the depth of the analysis.
×

Thank you! Your message has been sent.

    Get Case Study

    Improving the treatment care of patients with Multiple Myeloma through regular digital connection between International, National Experts and haematologists in Europe

      Get Brochure